Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients with Breast Cancer with Nodal Metastases

Study ID: NCT06092892
Start Date: 2024-04-07
End Date: 2031-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Breast Surgery (BCS or mastectomy) with TAD/SNB

Adjuvant Radiation Therapy

Sponsor

Alice Chung

Source: clinicaltrials.gov

Share:
Add to list

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Study ID: NCT06721689
Start Date: 2025-03-23
End Date: 2031-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

59

Intervention / Treatment

PEEL-224

Vincristine

Temozolomide (TMZ)

Sponsor

Theodore Laetsch

Source: clinicaltrials.gov

Share:
Add to list

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Study ID: NCT05828589
Start Date: 2023-06-20
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

112

Intervention / Treatment

BGB-21447

Sponsor

Beigene

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Study ID: NCT06045689
Start Date: 2023-10-05
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

100

Intervention / Treatment

Scales

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Study ID: NCT06478589
Start Date: 2025-01-02
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Adapted Patient Priorities Care (PPC) approach

Usual Care

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Study ID: NCT06934889
Start Date: 2025-04-07
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

60

Intervention / Treatment

ERAS-801

Abbv-637

Abbv-155

Temozolomide

Radiotherapy

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Study ID: NCT06176989
Start Date: 2024-03-04
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Enasasidib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Study ID: NCT05009992
Start Date: 2021-10-20
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

360

Intervention / Treatment

OnC201

Radiation Therapy

Pawalib

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

United against HPV

Study ID: NCT06825689
Start Date: 2025-01-28
End Date: 2029-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

735

Intervention / Treatment

Self-sampling with urine

Self-sampling with swab

In-clinic Pap/HPV co-testing

Sponsor

University of Texas at Austin

Source: clinicaltrials.gov

Share:
Add to list

PRO1107 in Patients With Advanced Solid Tumors

Study ID: NCT06171789
Start Date: 2024-01-29
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

280

Intervention / Treatment

Gen1107

Sponsor

Genmab

Source: clinicaltrials.gov

Share:
Add to list